AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Transplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsStem CellsTreatment OutcomeBusulfanGraft SurvivalLiver TransplantationGraft vs Leukemia EffectRecurrenceRemission InductionMyeloablative AgonistsHistocompatibility TestingBone MarrowWhole-Body IrradiationGraft vs Tumor EffectLeukemiaVidarabineSurvival RateImmunosuppressive AgentsLeukemia, Myeloid, AcuteRetrospective StudiesCombined Modality TherapyLymphocyte TransfusionBone Marrow CellsDisease-Free SurvivalHematopoietic Stem CellsSurvival AnalysisKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHistocompatibilityMultiple MyelomaCord Blood Stem Cell TransplantationAnemia, AplasticCytomegalovirus InfectionsLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesCyclophosphamideTime FactorsSalvage TherapyAntilymphocyte SerumSiblingsMinor Histocompatibility AntigensHepatic Veno-Occlusive DiseaseNeoplasm, ResidualMelphalanAntineoplastic Combined Chemotherapy ProtocolsVirus ActivationChimerismTransplantation ImmunologyHeart TransplantationAcute DiseaseT-LymphocytesCell TransplantationGraft RejectionFollow-Up StudiesMesenchymal Stem Cell TransplantationHLA AntigensImmunosuppressionTransplantation, IsogeneicHematopoietic Stem Cell MobilizationHematologic DiseasesLung TransplantationPrognosisCytomegalovirusLeukemia, MyeloidPrimary MyelofibrosisCytarabineAntigens, CD34Lymphoma, Non-HodgkinCyclosporineLeukemia, Myeloid, Accelerated PhaseOrgan TransplantationNuclear FamilyHodgkin DiseaseLeukocyte TransfusionLymphoproliferative DisordersImmunocompromised HostAntineoplastic AgentsLiving DonorsEmbryonic Stem CellsGranulocyte Colony-Stimulating FactorInfectionAntibodies, NeoplasmFusion Proteins, bcr-ablCell DifferentiationActuarial AnalysisFatal OutcomeMice, Inbred C57BLIslets of Langerhans TransplantationCell Survival

No FAQ available that match "marrow transplantation survival allogeneic stem cell transplantation"